Contact Person : Dana Wood; Last Date for the submission of abstract : 14/10/2010; Description : To discuss the opportunities and liabilities of targeting the PI 3-kinase pathway in disease, drawing on human pathophysiology and genetics, mouse models and (pre)clinical data with new PI 3-kinase inhibitors.